Hormonal Assays & Tumor Markers

Hormonal assays and tumor marker tests are vital diagnostic tools for evaluating endocrine function and detecting malignancies. At ROS CURE DIAGNOSTICS LLP, we offer a comprehensive panel of tests that aid in the diagnosis, monitoring, and management of hormonal disorders and cancers.

Hormonal Assays evaluate hormone levels in the blood to identify imbalances related to:

  • Thyroid disorders (TSH, T3, T4)
  • Reproductive health (FSH, LH, Prolactin, Estrogen, Testosterone, AMH)
  • Adrenal and pituitary function (Cortisol, ACTH, GH)
  • Diabetes and metabolism (Insulin, C-peptide)

Tumor Markers help in detecting cancer at an early stage, evaluating treatment effectiveness, and monitoring recurrence. Common markers include:

  • CA-125 (ovarian cancer)
  • CEA (colorectal and other cancers)
  • AFP (liver cancer)
  • PSA (prostate cancer)
  • CA 15-3, CA 19-9, Beta-hCG, NSE, and others

All tests are conducted using advanced immunoassay analyzers with stringent quality protocols, ensuring high sensitivity and specificity.

Key Highlights:

  • Early detection of endocrine and cancer-related conditions
  • Wide range of hormone and tumor marker tests
  • Expert analysis and clinical correlation
  • Minimal sample volume with efficient reporting
  • Essential for fertility evaluations, menstrual issues, and cancer risk assessment

ROS CURE DIAGNOSTICS LLP provides precise, timely, and actionable results to support better clinical outcomes and patient care.